肠道中的菌体-微生物群相互作用:对健康和治疗策略的影响
Ramtin Naderian1, Farnaz Alibabaei2, Elham Paraandavaji3
1Cancer Research Center, Semnan University of Medical Sciences, Semnan, Iran.
Probiotics and antimicrobial proteins
|October 1, 2025
概括
菌体 (感染细菌的病毒) 是肠道健康和打击抗生素耐药性的关键. 了解菌体与微生物群的相互作用推动了健康和疾病管理的新治疗策略.
科学领域:
- 微生物学 微生物学
- 免疫学 免疫学 免疫学
- 遗传学 是一个遗传学.
背景情况:
- 肠道微生物群,包括细菌,古生物,真菌,原生动物和病毒 (包括菌体),对人类健康至关重要,影响免疫力,维生素合成和病原体防御.
- 细菌菌体,特定的细菌病毒,正在成为抗生素治疗耐药感染的有希望的替代品,因为它们针对病原体的向作用,同时不影响有益的肠道细菌.
研究的目的:
- 检查细菌体和肠道微生物群之间的复杂相互作用.
- 阐明这些相互作用在维持健康和疾病中的作用.
- 突出肠道菌群在调节免疫和代谢功能的治疗潜力.
主要方法:
- 关于菌体-微生物群动态的当前文献的综述.
- 分析影响肠道微生物群恒温的因素 (例如饮食,年龄,药物).
- 探索先进技术,如高通量测序,CRISPR-Cas系统和病毒转基因组学,以研究菌体-微生物群相互作用.
主要成果:
- 菌体通过化和 lysogenic 循环显著影响肠道微生物群的组成和结构.
- 肠道菌群对宿主免疫反应和代谢健康产生重大影响.
- 尖端技术彻底改变了对菌体-微生物群相互作用的研究,使得人们能够更深入地了解.
结论:
- 了解菌体-微生物群相互作用对于理解微生物群落的稳定性和多样性至关重要.
- 肠道菌体对新型治疗干预有很大的潜力,包括基因工程菌体和菌体尾酒.
- 需要进一步的研究,以克服监管障碍和细菌耐药性等挑战,以推进基于菌体的疗法.
相关概念视频
Microorganisms in Medicine and Therapeutics
908
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
908
What is Monogastric Digestion?
74.8K
The human body contains a monogastric digestive system. In a monogastric digestive system, the stomach only contains one chamber in which it digests food. Several other animal species also have monogastric digestive systems, including pigs, horses, dogs, and birds. This chapter, however, focuses on the human digestive system.
74.8K
Fungal Phylum Microsporidia
367
Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
367
Bacterial Flora of the Large Intestine
1.5K
The gut microbiome is formed by a vast and diverse community of bacteria that colonizes our large intestine. These bacteria start residing in the gut from birth and continue diversifying throughout life, influenced by factors such as diet, lifestyle, and stress. The gut bacterial community also includes bacteria from food and those that enter the colon through the anus.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
1.5K
Gene Regulation in Microbial Communities: Quorum Sensing
451
Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
451
Inflammatory Bowel Disease IV: Pharmacological Management
427
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
427


